Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

A new study from researchers at the Oregon Health and Science University (OHSU) proposes a test called PAC-MANN, which could ...

A ‘tumour-on-chip’ model on PDAC has been developed to allow insights into interactions between tumour cells and potential ...

According to the American Cancer Society, people diagnosed with pancreatic cancer have a 13% chance of living five years ...

The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...

Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of ...

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.